Production Facilities

Production and Stable Supplies

Focused on cost management in preparation for NHI drug price scheme reforms and the 80% generic pharmaceutical era while further strengthening stable supply capabilities

Strengthening Stable Supply Capabilities

Strengthening Stable Supply Capabilities

While we take pride in having the largest supply capacity in the industry, we also believe it vital to strengthen stable supply capabilities in order to meet the government’s target for generics accounting for 80% of patent expired pharmaceutical volume. Sawai is focused on improving efficiency and reducing workloads, through such methods as the establishment of fixed work shifts and the bolstering of yields. We are also considering subcontracting production of some products to outside sources. Sawai aims to bolster its stable supply capabilities by encouraging cooperation and achieving the best division of production among its seven production locations, including the Sanda Nishi Factory, which is now in operation following the completion of construction in 2016.

Strong Emphasis on Cost Controls

Sawai believes the impact of NHI drug price reductions and heightened competition is likely to result in lower unit selling prices, even if sales volume increases. While committed to maintaining stable supply and high levels of quality, we are also focusing on controlling costs. This includes efforts to improve efficiency in production through manufacturing and sales tie-ups, diversifying business partners in areas such as raw materials, and conducting regular reviews in the terms of trade.

Initiatives to Maintain Stable Supplies

Further Consolidating Supply Capacity by Increasing Packaging Capacity. To prepare for the expansion in demand that is forecast in the years ahead, Sawai is increasing its packaging capacity to provide stable supplies of high-quality generics. By constructing the new Sanda Nishi Factory, Sawai will be able to install manufacturing machinery in the space now used for packaging in the Sanda Factory. The capacity of the Sanda Factory will increase from 3.9 billion tablets to 4.8 billion tablets a year.

Expansion of Sawai’s Production Capacity

Expansion of Sawai’s Production Capacity
Operation
Products
Research and Development
Production Facilities
Other
Back to Top